drugset / Trial / NCT02338778
Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safeness and effectiveness of mix vaccine (MV). Enrolled patients will receive standard treatment according to National Comprehensive Cancer Network (NCCN) guide line with or without combining MV injection. The efficacy and side effect will be compared between the two groups.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MV | Unknown | 0.5 ml | Intravenous |